Starling Oncology, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
Starling Oncology, Inc. (STLN) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $137.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-03-12
- Starling Oncology, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was $137.00K, a 2640.00% increase from fiscal 2024.
- Starling Oncology, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2024 was $5.00K.
- Starling Oncology, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Starling Oncology, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was $5.00K, a 96.45% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month |
|---|---|
| 2025-12-31 | $137.00K 10-K · filed 2026-03-12 |
| 2024-12-31 | $5.00K 10-K · filed 2026-03-12 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-26 |
| 2022-12-31 | $5.00K 10-K · filed 2024-03-28 |
| 2021-12-31 | $141.00K 10-K · filed 2023-03-16 |
| 2020-12-31 | $3.00K 10-K · filed 2022-03-11 |